The Drug Regulatory Authority of Pakistan (DRAP) has rejected reports of a recent increase in the prices of essential medicines, describing them as baseless. A DRAP spokesperson stated that there has been no increase in the prices of insulin and other life-saving drugs. Pharmaceutical companies are not permitted to raise the prices of essential medicines



